GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Selective Activators of Nrf2 for Neurodegenerative Disease

$246,702
Paul Anthony Bertin · Grove Biopharma, Inc. · R43 · FY2023 · NS

Molecular control of tolerogenic dendritic cell function

$246,623
Amanda W. Lund · New York University School Of Medicine · R21 · FY2025 · AI

Patient-adjustable MRI technology for high-resolution imaging of deep brain stimulation

$246,549
Laleh Golestani Rad · Northwestern University At Chicago · R00 · FY2018 · EB

The regulation of myeloid cell development and mobilization during autoimmune dem

$246,522
Benjamin Matthew Segal · University Of Michigan At Ann Arbor · R01 · FY2013 · NS

Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di

$246,510
Robert C Axtell · Oklahoma Medical Research Foundation · R00 · FY2014 · NS

DEVELOPMENT OF A NOVEL SELECTIVE PDE4 INHIBITOR FOR THE TREATMENT OF MULTIPLE SCLEROSIS

$246,443
Fannin Partners Llc · · FY2024 · Defense Health Agency

DATA PROCESSING FOR MR SPECTROSCOPIC IMAGING

$246,437
University Of Miami School Of Medicine · R01 · FY2003 · EB

Astrocyte Regulation of Neural Plasticity After CNS Injury

$246,432
Joshua Evan Burda · Cedars-Sinai Medical Center · R00 · FY2021 · NS

Developing fluorescent probes for the endogenous gaseous transmitters NO and H2S

$246,343
Michael Pluth · University Of Oregon · R00 · FY2012 · GM

Autoantibody depletion for the therapy of autoimmune disease

$246,229
Sunil Kannanganat Sidharthan · Astero Erado Inc · R43 · FY2021 · AI

aire a zinc-finger protein that controls autoimmunity

$246,218
Diane J Mathis · Joslin Diabetes Center · R01 · FY2009 · DK

Project 5

$246,093
Bibhuti Bhusan Mishra · University Of North Dakota · P20 · FY2019 · GM

Project 5

$246,093
Bibhuti Bhusan Mishra · University Of North Dakota · P20 · FY2018 · GM

Endocannabinoids in COX-2-Mediated Synaptic Modification and Neurotoxicity

$246,015
Chu Chen · Lsu Health Sciences Center · R01 · FY2010 · NS

Small Molecule Induced Astrogliogenesis

$246,000
Jeffrey D Rothstein · Johns Hopkins University · R21 · FY2011 · NS

Modulation of Wnt Signaling in Models of Multiple Sclerosis

$246,000
Wendy Gilmore · University Of Southern California · R21 · FY2012 · NS

Detailed molecular and structural characterization of the meninges: an approach combining proteomics and Imaging Mass Cytometry

$246,000
Joel S Pachter · University Of Connecticut Sch Of Med/Dnt · R21 · FY2023 · NS

Prospective Study of Vitamin D and Multiple Sclerosis

$246,000
Harvard University (Sch Of Public Hlth) · R01 · FY2005 · NS

A Novel PET Ligand for PBR Imaging

$246,000
Christopher J Endres · Johns Hopkins University · R21 · FY2009 · MH

A Novel PET Ligand for PBR Imaging

$246,000
Christopher J Endres · Johns Hopkins University · R21 · FY2010 · MH

PROBING A NEW RISK CELL TYPE TO TREAT MULTIPLE SCLEROSIS

$246,000
The University Of Texas Southwestern Medical Center · · FY2021 · Department of the Army

Dimethyl fumarate attenuation of opioid withdrawal symptom severity

$245,993
Marc J Kaufman · Mclean Hospital · U18 · FY2020 · DA

Project 3: Models of neurodegenerative aggregate formation

$245,980
Robert Joseph Shmookler-Reis · Univ Of Arkansas For Med Scis · P01 · FY2016 · AG

Project 5

$245,946
Bibhuti Bhusan Mishra · University Of North Dakota · P20 · FY2016 · GM

Core D

$245,875
Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2020 · NS